Natco Pharma raises $142m from primary share sale
India’s Natco Pharma raised Rp9.15bn ($142m) this week, using a qualified institutional placement to sell the new stock.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts